4equ
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4equ]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4EQU OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4EQU FirstGlance]. <br> | <table><tr><td colspan='2'>[[4equ]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4EQU OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4EQU FirstGlance]. <br> | ||
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1PE:PENTAETHYLENE+GLYCOL'>1PE</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=G6I:N-{3-[(3-{4-[(4-METHOXYPHENYL)AMINO]-1,3,5-TRIAZIN-2-YL}PYRIDIN-2-YL)AMINO]-4-METHYLPHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE'>G6I</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> |
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1PE:PENTAETHYLENE+GLYCOL'>1PE</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=G6I:N-{3-[(3-{4-[(4-METHOXYPHENYL)AMINO]-1,3,5-TRIAZIN-2-YL}PYRIDIN-2-YL)AMINO]-4-METHYLPHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE'>G6I</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4equ FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4equ OCA], [https://pdbe.org/4equ PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4equ RCSB], [https://www.ebi.ac.uk/pdbsum/4equ PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4equ ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4equ FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4equ OCA], [https://pdbe.org/4equ PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4equ RCSB], [https://www.ebi.ac.uk/pdbsum/4equ PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4equ ProSAT]</span></td></tr> | ||
</table> | </table> | ||
Current revision
Human STK-10 (LOK) kinase domain in DFG-out conformation with inhibitor DSA-7
| |||||||||||
